Literature DB >> 15590460

The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function.

Nesrine Awad1, Michèle Gagnon, Claude Messier.   

Abstract

The present review integrates findings of published studies that have evaluated the cognitive function of treated and untreated type 2 diabetic patients and provides a detailed overview of the neuropsychological assessments conducted. Cognitive deficits are observed in older people with glucose intolerance or untreated diabetes but these deficits appear to be attenuated by treatments that improve glycemic control. Cognitive decrements in treated type 2 diabetic patients are most consistently observed on measures of verbal memory (35% of the measures) and processing speed (45% of the measures) while preserved function is observed on measures of visuospatial, attention, semantic and language function. Some studies suggest that deficits in cognitive functions are associated with poorer glycemic control. A number of other factors, such as depression, cardiovascular and cerebrovascular disease, increase these deficits. We conclude that, in diabetic patients who achieve and maintain good glycemic control, type 2 diabetes only has a small impact on cognitive functions before the age of 70 years. However, early onset of type 2 diabetes, poor glycemic control and the presence of micro- and macrovascular disease may interact to produce early cognitive deficits. In older adults (70 years and over), diabetes likely interacts with other dementing processes such as vascular disease and Alzheimer's disease to hasten cognitive decline.

Entities:  

Mesh:

Year:  2004        PMID: 15590460     DOI: 10.1080/13803390490514875

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  152 in total

Review 1.  Type 2 diabetes mellitus, dyslipidemia, and Alzheimer's disease.

Authors:  Cynthia M Carlsson
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 2.  Diabetes type II: a risk factor for depression-Parkinson-Alzheimer?

Authors:  Peter Riederer; Jasmin Bartl; Gerd Laux; Edna Grünblatt
Journal:  Neurotox Res       Date:  2010-06-15       Impact factor: 3.911

3.  Cognitive impairment in nondiabetic middle-aged and older adults is associated with insulin resistance.

Authors:  H Bruehl; V Sweat; J Hassenstab; V Polyakov; A Convit
Journal:  J Clin Exp Neuropsychol       Date:  2010-06       Impact factor: 2.475

Review 4.  Can bariatric surgery reduce risk of Alzheimer's disease?

Authors:  Kelly M Stanek; John Gunstad
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-07-04       Impact factor: 5.067

5.  Higher Fasting Plasma Glucose Levels, within the Normal Range, are Associated with Decreased Processing Speed in High Functioning Young Elderly.

Authors:  Meytal Raizes; Odelia Elkana; Motty Franko; Ramit Ravona Springer; Shlomo Segev; Michal Schnaider Beeri
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

6.  Genetic factors moderate everyday physical activity effects on executive functions in aging: Evidence from the Victoria Longitudinal Study.

Authors:  Sherilyn Thibeau; G Peggy McFall; Sandra A Wiebe; Kaarin J Anstey; Roger A Dixon
Journal:  Neuropsychology       Date:  2016-01       Impact factor: 3.295

7.  Heritability and genetic association analysis of cognition in the Diabetes Heart Study.

Authors:  Amanda J Cox; Christina E Hugenschmidt; Laura M Raffield; Carl D Langefeld; Barry I Freedman; Jeff D Williamson; Fang-Chi Hsu; Donald W Bowden
Journal:  Neurobiol Aging       Date:  2014-03-11       Impact factor: 4.673

Review 8.  Cognitive Impairment in CKD: Pathophysiology, Management, and Prevention.

Authors:  David A Drew; Daniel E Weiner; Mark J Sarnak
Journal:  Am J Kidney Dis       Date:  2019-08-01       Impact factor: 8.860

9.  Short-term longitudinal trends in cognitive performance in older adults with type 2 diabetes.

Authors:  Ashley L Fischer; Cindy M de Frias; Sophie E Yeung; Roger A Dixon
Journal:  J Clin Exp Neuropsychol       Date:  2009-02-17       Impact factor: 2.475

10.  Caffeine prevents weight gain and cognitive impairment caused by a high-fat diet while elevating hippocampal BDNF.

Authors:  Gregory A Moy; Ewan C McNay
Journal:  Physiol Behav       Date:  2012-12-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.